Armstrong, Matthew J
Barton, Darren
Gaunt, Piers
Hull, Diana
Guo, Kathy
Stocken, Deborah
Gough, Stephen C L
Tomlinson, Jeremy W
Brown, Rachel M
Hübscher, Stefan G
Newsome, Philip N
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
GLP-1 based therapies: clinical implications for gastroenterologists
https://doi.org/10.1136/gutjnl-2015-310572
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
https://doi.org/10.1136/gutjnl-2019-319104
OC-016 Liraglutide is effective in the histological clearance of non-alcoholic steatohepatitis in a multicentre, double-blinded, randomised, placebo-controlled phase ii trial
https://doi.org/10.1136/gutjnl-2015-309861.16
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
https://doi.org/10.1016/s0140-6736(15)00803-x
Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
https://doi.org/10.1136/bmjopen-2013-003995